Emerging evidence calls for new standards in adolescent hyperandrogenism :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Bridging gaps in adolescent hyperandrogenism diagnosis and therapy

Adolescent hyperandrogenism Adolescent hyperandrogenism
Adolescent hyperandrogenism Adolescent hyperandrogenism

What's new?

Adolescent hyperandrogenism demands puberty-specific diagnostics and integrated, evidence-based care to balance hormonal, metabolic, and mental health outcomes.

Adolescent hyperandrogenism, often linked to polycystic ovary syndrome (PCOS), androgen-secreting tumors, and non-classic congenital adrenal hyperplasia presents major diagnostic challenges due to its overlap with normal puberty. Hence, this narrative review assessed diagnostic accuracy and treatment efficacy, underscoring the need for puberty-specific criteria and integrated, multidisciplinary care.

Researchers examined evidence from PubMed, Scopus, Web of Science, EMBASE, and Cochrane (2000–2025), prioritizing the 2023 PCOS guidelines, randomized trials, and large cohort studies (n ≥ 50). Non–peer-reviewed sources were excluded. Data from 122 studies were analyzed to evaluate safety, and quality-of-life outcomes.

Diagnostic Frameworks Still Lack Adolescent-Specific Precision

The study highlighted significant shortcomings in current diagnostic approaches. Age-specific biochemical cutoffs for testosterone, dehydroepiandrosterone sulfate (DHEA-S), and 17-hydroxyprogesterone remain poorly defined in adolescents, leading to inconsistent diagnoses.

Similarly, imaging criteria—particularly ovarian ultrasound findings—are often unreliable in teenagers due to rapid pubertal ovarian changes. The authors note that applying adult imaging thresholds may lead to overdiagnosis or unnecessary anxiety.

Therapeutic Landscape: Beyond Combined Oral Contraceptives

Combined oral contraceptives (COCs) continue to serve as first-line therapy for menstrual regulation and androgen suppression. However, emerging data underscore pivotal considerations:

  • Metabolic risks with prolonged COC use remain an ongoing concern.
  • Insulin sensitizers, including myo-inositol, illustrate growing promise as adjunctive or alternative therapies, especially in adolescents with metabolic features.
  • Evidence for anti-androgen medications in this age group remains limited and warrants further long-term study.

Mental Health: A Major Yet Overlooked Component

One of the most striking findings is the high prevalence of psychological comorbidities. Anxiety and depression affect 38–45% of adolescents with hyperandrogenism, yet mental health screening is inconsistently integrated into routine care.

Experts emphasize that a purely hormonal approach is insufficient. A multidisciplinary model incorporating dermatology, gynecology, endocrinology, and psychology is fundamental to improve long-term outcomes.

Critical Gaps Highlighted for Future Research

The authors call for urgent research addressing three major gaps:

  1. Validated diagnostic thresholds tailored to age, ethnicity, and pubertal stage
  2. Long-term safety data on hormonal treatments and emerging therapies
  3. Standardized mental health protocols alongside endocrine management

A Roadmap for Individualized Care

As adolescent hyperandrogenism continues to rise, the review stresses the requisition for evidence-based, patient-centered care pathways. Establishing age-appropriate reference standards, exploring safer therapeutic options, and embedding psychological support into routine practice will be key to improving health trajectories.

Source:

World Journal of Pediatrics

Article:

Adolescent hyperandrogenism: diagnostic challenges and therapeutic approaches

Authors:

Marcio J. Concepción-Zavaleta et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: